José Antonio Mata‐Marín
- Virology top 10%
- HIV Research and Treatment 13
- Hepatology top 10%
- Hepatitis C virus research 12
- Infectious Diseases top 10%
- HIV/AIDS drug development and treatment 20
- HIV/AIDS Research and Interventions 10
- Emergency Medicine top 10%
- HIV-related health complications and treatments 10
-
- Hepatitis B Virus Studies 7
- Liver Disease Diagnosis and Treatment 6
- Pneumocystis jirovecii pneumonia detection and treatment 3
José Antonio Mata‐Marín
40 papers receiving 259 citations
Peers
Comparison fields: 5 of 52
- Virology 78
- Hepatology 101
- Infectious Diseases 121
- Emergency Medicine 61
- Epidemiology 150
Countries citing papers authored by José Antonio Mata‐Marín
This map shows the geographic impact of José Antonio Mata‐Marín's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by José Antonio Mata‐Marín with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites José Antonio Mata‐Marín more than expected).
Fields of papers citing papers by José Antonio Mata‐Marín
This network shows the impact of papers produced by José Antonio Mata‐Marín. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by José Antonio Mata‐Marín. The network helps show where José Antonio Mata‐Marín may publish in the future.
Co-authorship network
The 25 scholars most cited alongside José Antonio Mata‐Marín, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 6 | |
| 3 | 2023 | 10 | |
| 4 | 2022 | 7 | |
| 5 | 2020 | 2 | |
| 6 | 2020 | 2 | |
| 7 | 2019 | 5 | |
| 8 | 2018 | 6 | |
| 9 | 2018 | 8 | |
| 10 | 2018 | 5 | |
| 11 | 2017 | 3 | |
| 12 | 2016 | 2 | |
| 13 | 2016 | 1 | |
| 14 | 2016 | 1 | |
| 15 | 2015 | 9 | |
| 16 | 2015 | 4 | |
| 17 | Intensification of treatment with pegylated interferon alfa in patients coinfected with HIV and HBV genotype H or G being treated with a tenofovir/emtricitabine-containing regimen. | 2014 | 5 |
| 18 | 2014 | 7 | |
| 19 | 2014 | 8 | |
| 20 | The prevalence of depressive symptons and cognitive impaiment in patients older than 65 years admitted to a general hospital | 1998 | 2 |
About José Antonio Mata‐Marín
José Antonio Mata‐Marín is a scholar working on Virology, Hepatology and Infectious Diseases, having authored 41 papers that have together received 273 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (20 papers), HIV Research and Treatment (13 papers), Hepatitis C virus research (12 papers), HIV/AIDS Research and Interventions (10 papers), HIV-related health complications and treatments (10 papers), Hepatitis B Virus Studies (7 papers), Liver Disease Diagnosis and Treatment (6 papers) and Pneumocystis jirovecii pneumonia detection and treatment (3 papers). The work is most often cited by research in Virology (78 citations), Hepatology (101 citations) and Infectious Diseases (121 citations). José Antonio Mata‐Marín has collaborated with scholars based in Mexico, Germany and Argentina. Frequent co-authors include Jesús Gaytán-Martı́nez, José Luis Fuentes-Allen, Stefan Mauss, Edgar Pérez‐Barragán, Rosa María Ribas‐Aparicio, Fortino Solórzano‐Santos, Ericka N. Pompa‐Mera, Iván de Jesús Ascencio-Montiel, Ashuin Kammar‐García and Jorge Vela‐Ojeda. Their work appears in journals such as PLoS ONE, AIDS and World Journal of Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.